Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03848949 · ClinicalTrials.gov registry record · NA

Study of an Orthotic Designed to Equalize Leg Lengths for Patients With Injuries Managed in Walking Boots

A NA study, sponsored by Rush University Medical Center.

Completed
Registry status
NA
Development phase
107
Enrollment target

NCT03848949: Completed NA study, sponsored by Rush University Medical Center.

NCT03848949 is a NA study that has completed, run by Rush University Medical Center. The registered enrollment target is 107 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03848949, a NA study, has completed, sponsored by Rush University Medical Center.

COMPLETED
Registry status
NA
Development phase
107 participants
Enrollment target

Study Summary

Patients who undergo foot and ankle surgery are often made weight-bearing as tolerated (WBAT) in a controlled ankle movement (CAM) boot during their recovery and rehabilitation process. However, some patients may experience pain and discomfort while wearing the CAM boot. A possible cause for this pain is that the boot elevates the injured foot higher than the other foot in the normal shoe. This uneven walking plane can lead to an abnormal gait or walking pattern, and may potentially lead to pain. Our goal is the investigate if using a leg-length-evening orthotic can improve balance and/or decrease the development of pain in the legs and spine for patients who are WBAT in a CAM boot.

Primary Outcome

Patient reported assessment of their balance while wearing the controlled ankle movement boot on a scale of 1 - 10 (higher values indicate better balance).

Interventions

  • DEVICE Evenup

Trial Details

FieldValue
Enrollment Target 107 participants
Start Date 2018-07-16
Est. Completion 2019-12-01
Phase NA
Rush University Medical Center

320 total trials

What the finished NCT03848949 record still lists

NCT03848949 is an interventional study that assigns participants to a tested intervention. The registered 107 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).

The record links to 0 conditions, and to 1 intervention - of which Evenup is the first listed.

NCT03848949 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03848949 about?

NCT03848949 is a clinical study titled "Study of an Orthotic Designed to Equalize Leg Lengths for Patients With Injuries Managed in Walking Boots". Patients who undergo foot and ankle surgery are often made weight-bearing as tolerated (WBAT) in a controlled ankle movement (CAM) boot during their recovery and rehabilitation process. However, some patients may experience pain and discomfort while wearing the CAM boot. A possible cause for this pa...

What is the current status of trial NCT03848949?

This trial is currently completed. It is a NA study. The enrollment target is 107 participants. The study started on 2018-07-16. Estimated completion is 2019-12-01.

What interventions are being tested in trial NCT03848949?

The interventions under investigation include: Evenup (DEVICE).

Who is sponsoring clinical trial NCT03848949?

This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03848949's enrollment target sits among peer trials

107 830th of 2000 higher than 1,171 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05491668 · 107 participants

    Physiological Assessment of Severe Coronary Stenosis for Informing Planned PCI

  • NCT06041594 · 107 participants · NA

    Treating Pulmonary Embolism With Laguna Thrombectomy System (TRUST)

  • NCT06081426 · 107 participants · NA

    Examining Neurobiological Mechanisms Underlying the Therapeutic Effect of the Ketogenic Diet in Bipolar Disorder (BD)

  • NCT06527599 · 107 participants · NA

    Screening in Trauma for Opioid Misuse Prevention - an Adaptive Intervention

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03848949, the US trial registry maintained by the National Library of Medicine. NCT03848949 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.